Hassan Bousbaa
AuthID: R-000-5PY
11
TITLE: Novel Anticancer Strategies II Full Text
AUTHORS: Bousbaa, Hassan;
PUBLISHED: 2023, SOURCE: PHARMACEUTICS, VOLUME: 15, ISSUE: 2
AUTHORS: Bousbaa, Hassan;
PUBLISHED: 2023, SOURCE: PHARMACEUTICS, VOLUME: 15, ISSUE: 2
12
TITLE: Discovery of a New Chalcone-Trimethoxycinnamide Hybrid with Antimitotic Effect: Design, Synthesis, and Structure-Activity Relationship Studies Full Text
AUTHORS: Moreira, Joana; Silva, Patricia M. A.; Barros, Matilde; Saraiva, Lucilia ; Pinto, Madalena; Bousbaa, Hassan; Cidade, Honorina ;
PUBLISHED: 2023, SOURCE: PHARMACEUTICALS, VOLUME: 16, ISSUE: 6
AUTHORS: Moreira, Joana; Silva, Patricia M. A.; Barros, Matilde; Saraiva, Lucilia ; Pinto, Madalena; Bousbaa, Hassan; Cidade, Honorina ;
PUBLISHED: 2023, SOURCE: PHARMACEUTICALS, VOLUME: 16, ISSUE: 6
13
TITLE: Combination Therapy as a Promising Way to Fight Oral Cancer Full Text
AUTHORS: Silva, Joao P. N.; Pinto, Barbara; Monteiro, Luis; Silva, Patricia M. A.; Bousbaa, Hassan;
PUBLISHED: 2023, SOURCE: PHARMACEUTICS, VOLUME: 15, ISSUE: 6
AUTHORS: Silva, Joao P. N.; Pinto, Barbara; Monteiro, Luis; Silva, Patricia M. A.; Bousbaa, Hassan;
PUBLISHED: 2023, SOURCE: PHARMACEUTICS, VOLUME: 15, ISSUE: 6
14
TITLE: BUB3, beyond the Simple Role of Partner Full Text
AUTHORS: Silva, Patricia M. A.; Bousbaa, Hassan;
PUBLISHED: 2022, SOURCE: PHARMACEUTICS, VOLUME: 14, ISSUE: 5
AUTHORS: Silva, Patricia M. A.; Bousbaa, Hassan;
PUBLISHED: 2022, SOURCE: PHARMACEUTICS, VOLUME: 14, ISSUE: 5
15
TITLE: Navitoclax Enhances the Therapeutic Effects of PLK1 Targeting on Lung Cancer Cells in 2D and 3D Culture Systems Full Text
AUTHORS: Pinto, Barbara; Novais, Pedro; Henriques, Ana C.; Carvalho Tavares, Juliana; Silva, Patricia M. A.; Bousbaa, Hassan;
PUBLISHED: 2022, SOURCE: PHARMACEUTICS, VOLUME: 14, ISSUE: 6
AUTHORS: Pinto, Barbara; Novais, Pedro; Henriques, Ana C.; Carvalho Tavares, Juliana; Silva, Patricia M. A.; Bousbaa, Hassan;
PUBLISHED: 2022, SOURCE: PHARMACEUTICS, VOLUME: 14, ISSUE: 6
16
TITLE: BUBR1 as a Prognostic Biomarker in Canine Oral Squamous Cell Carcinoma Full Text
AUTHORS: Delgado, Leonor; Monteiro, Luis; Silva, Patricia; Bousbaa, Hassan; Garcez, Fernanda; Silva, Joao; Brilhante Simoes, Paula; Pires, Isabel; Prada, Justina;
PUBLISHED: 2022, SOURCE: ANIMALS, VOLUME: 12, ISSUE: 22
AUTHORS: Delgado, Leonor; Monteiro, Luis; Silva, Patricia; Bousbaa, Hassan; Garcez, Fernanda; Silva, Joao; Brilhante Simoes, Paula; Pires, Isabel; Prada, Justina;
PUBLISHED: 2022, SOURCE: ANIMALS, VOLUME: 12, ISSUE: 22
17
TITLE: Chiral derivatives of xanthones and benzophenones: Synthesis, enantioseparation, molecular docking, and tumor cell growth inhibition studies Full Text
AUTHORS: Phyo, YZ; Teixeira, J; Goncalves, R; Palmeira, A ; Tiritan, ME ; Bousbaa, H; Pinto, MMM; Fernandes, C ; Kijjoa, A ;
PUBLISHED: 2021, SOURCE: CHIRALITY, VOLUME: 33, ISSUE: 4
AUTHORS: Phyo, YZ; Teixeira, J; Goncalves, R; Palmeira, A ; Tiritan, ME ; Bousbaa, H; Pinto, MMM; Fernandes, C ; Kijjoa, A ;
PUBLISHED: 2021, SOURCE: CHIRALITY, VOLUME: 33, ISSUE: 4
18
TITLE: Antagonizing the spindle assembly checkpoint silencing enhances paclitaxel and Navitoclax-mediated apoptosis with distinct mechanistic Full Text
AUTHORS: Henriques, AC; Silva, PMA; Sarmento, B; Bousbaa, H;
PUBLISHED: 2021, SOURCE: SCIENTIFIC REPORTS, VOLUME: 11, ISSUE: 1
AUTHORS: Henriques, AC; Silva, PMA; Sarmento, B; Bousbaa, H;
PUBLISHED: 2021, SOURCE: SCIENTIFIC REPORTS, VOLUME: 11, ISSUE: 1
19
TITLE: Cytotoxic effects of submicron- and nano-scale titanium debris released from dental implants: an integrative review Full Text
AUTHORS: Messous, R; Henriques, B; Bousbaa, H; Silva, FS; Teughels, W; Souza, JCM;
PUBLISHED: 2021, SOURCE: CLINICAL ORAL INVESTIGATIONS, VOLUME: 25, ISSUE: 4
AUTHORS: Messous, R; Henriques, B; Bousbaa, H; Silva, FS; Teughels, W; Souza, JCM;
PUBLISHED: 2021, SOURCE: CLINICAL ORAL INVESTIGATIONS, VOLUME: 25, ISSUE: 4
20
TITLE: Novel Anticancer Strategies Full Text
AUTHORS: Bousbaa, H;
PUBLISHED: 2021, SOURCE: PHARMACEUTICS, VOLUME: 13, ISSUE: 2
AUTHORS: Bousbaa, H;
PUBLISHED: 2021, SOURCE: PHARMACEUTICS, VOLUME: 13, ISSUE: 2
